CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 230 filers reported holding CONMED CORP in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,534,361 | +704.6% | 25,130 | +1085.9% | 0.06% | +326.7% |
Q1 2022 | $315,000 | +38.2% | 2,119 | +27.6% | 0.02% | -21.1% |
Q2 2021 | $228,000 | -58.8% | 1,661 | -66.4% | 0.02% | -67.8% |
Q4 2020 | $554,000 | +0.5% | 4,942 | -35.4% | 0.06% | +55.3% |
Q2 2020 | $551,000 | -56.8% | 7,647 | -65.7% | 0.04% | -59.1% |
Q1 2020 | $1,276,000 | +129.9% | 22,280 | +349.0% | 0.09% | +181.8% |
Q4 2019 | $555,000 | -2.8% | 4,962 | -27.7% | 0.03% | -19.5% |
Q1 2019 | $571,000 | +149.3% | 6,860 | +137.4% | 0.04% | +141.2% |
Q3 2018 | $229,000 | -41.0% | 2,890 | -62.0% | 0.02% | -60.5% |
Q4 2017 | $388,000 | -48.3% | 7,610 | -55.0% | 0.04% | -55.2% |
Q1 2017 | $751,000 | +147.9% | 16,900 | +134.3% | 0.10% | +166.7% |
Q1 2016 | $303,000 | -27.5% | 7,213 | -24.1% | 0.04% | -2.7% |
Q4 2015 | $418,000 | +32.7% | 9,500 | +43.9% | 0.04% | +37.0% |
Q3 2015 | $315,000 | – | 6,600 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |